34
Participants
Start Date
July 1, 2024
Primary Completion Date
June 30, 2026
Study Completion Date
June 30, 2027
second allogeneic stem cell transplantation
"1. Change another donor if possible~2. Conditioning regimen: fludarabine (30mg/m2/day, days -6 to -2 ), cyclophosphamide (1g/m2/day, days -5 to -4)~3. GVHD prophylaxis: cyclosporine A (concentration 150-250ng/ml), mycophenolate mofetil (0.5g bid -3d to neutrophil engraftment)+anti CD25 monoAb (20mg -1d, +4d, +15d)"
RECRUITING
Peking University People's Hospital, Beijing
The First Affiliated Hospital of Soochow University
OTHER
Ruijin Hospital
OTHER
Zhejiang University
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
Shandong Provincial Hospital
OTHER_GOV
Guangdong Provincial Hospital of Traditional Chinese Medicine
OTHER
First Affiliated Hospital of Fujian Medical University
OTHER
Hebei Yanda Ludaopei Hospital
OTHER
Tongji Hospital
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Peking University First Hospital
OTHER
Jiangsu Provincial People's Hospital
OTHER
Shengjing Hospital
OTHER
Xinqiao Hospital of Chongqing
OTHER
Nanfang Hospital, Southern Medical University
OTHER
First Affiliated Hospital of Guangxi Medical University
OTHER
Anhui Provincial Hospital
OTHER_GOV
Peking University People's Hospital
OTHER